At a glance

  • A validated blood test—not symptoms or a home glucose meter—establishes the diagnosis.
  • Treatment choices depend on more than glucose, including heart and kidney health, side effects, access, and personal priorities.
  • Regular monitoring can find complications early, when action is often more effective.

01

What type 2 diabetes is

It is a long-term metabolic condition, but its course and treatment needs differ substantially from one person to another.

Insulin helps glucose move from the blood into cells for energy. In type 2 diabetes, cells respond less effectively to insulin and the pancreas may eventually be unable to meet demand. Blood glucose then remains too high. This is not simply a disease of willpower or sugar consumption: genes, age, body-fat distribution, sleep, medicines, health conditions, food access, activity, stress, and the surrounding environment can all influence risk and control.

Sources for this section: [1] [3]

02

Symptoms and how it may present

Many people have no obvious symptoms, so testing based on risk can matter.

Symptoms usually develop gradually and can be mistaken for ordinary fatigue or aging. Increased thirst or urination, blurred vision, recurrent infections, slow-healing wounds, unexplained weight change, tiredness, or tingling in the hands or feet can occur. Some people first learn they have diabetes during routine testing or after a related heart, kidney, eye, or nerve problem is found. Symptoms cannot show how high the glucose is or identify the diabetes type.

  • Ask about testing if symptoms occur or if your age, family history, pregnancy history, medicines, or other conditions raise risk.
  • Do not use a consumer glucose meter to diagnose diabetes; laboratory confirmation is needed.

Sources for this section: [1] [2]

03

Causes, risk, and prevention

Type 2 diabetes results from interacting biological and environmental factors. Risk rises with family history, increasing age, prior gestational diabetes, some medicines and endocrine conditions, and metabolic factors such as insulin resistance. Weight can be relevant, but people in smaller bodies also develop diabetes and BMI does not describe fat distribution or individual risk well. For people with prediabetes or high risk, structured changes in activity and eating—and sometimes metformin—can delay or prevent diabetes, but prevention advice should not become blame.

Sources for this section: [1] [3]

04

Diagnosis and tests

A clinician interprets laboratory results in context and usually confirms an abnormal result.

Diagnosis can use HbA1c, fasting plasma glucose, an oral glucose tolerance test, or random plasma glucose when classic symptoms are present. Unless glucose is unequivocally high with symptoms, two abnormal results are generally used to confirm diabetes. HbA1c can be less reliable in pregnancy, some anemias, recent blood loss or transfusion, kidney disease, and with certain hemoglobin variants. A clinician may order additional tests when the diabetes type is uncertain.

Common diagnostic tests and what they represent
TestWhat it reflectsImportant context
HbA1cApproximate average glucose over several monthsSome blood conditions and pregnancy can affect accuracy
Fasting plasma glucoseGlucose after a defined fasting periodIllness, medicines, and preparation can influence the result
Oral glucose tolerance testResponse to a measured glucose drinkMore time-consuming but useful in selected situations

Sources for this section: [2] [3]

05

Treatment options

The best plan treats the person’s overall risk and goals, not one glucose number in isolation.

Some people initially reach goals through changes in food, activity, sleep, and weight where relevant; many need medicine at diagnosis or later. Metformin is common, while SGLT2 inhibitors or GLP-1 receptor agonists may be prioritized for some people with heart disease, heart failure, kidney disease, or weight-related goals. Other tablets, injectable medicines, insulin, and metabolic surgery have roles. Choices should account for benefit, low-glucose risk, side effects, pregnancy plans, kidney and liver function, cost, access, and preferences.

How major treatment groups differ
OptionWhy it may be chosenPoints to discuss
MetforminEstablished glucose-lowering option with broad experienceDigestive effects, kidney function, vitamin B12, and tolerance
SGLT2 inhibitorMay add heart-failure or kidney benefit in suitable peopleGenital infections, dehydration, ketoacidosis risk, and sick-day instructions
GLP-1–based medicineGlucose lowering, weight effects, and cardiovascular benefit for selected peopleDigestive effects, gallbladder or pancreatic history, access, and long-term plan
Insulin or other medicinesNeeded when glucose is markedly high or other options do not meet the goalLow glucose, monitoring, technique, schedule, and affordability

Sources for this section: [4] [5]

06

Food, activity, and supportive care

There is no single diabetes diet. A useful pattern emphasizes vegetables, beans, minimally processed grains and foods, appropriate protein, unsaturated fats, and drinks without large amounts of added sugar while fitting culture, budget, appetite, and medicine timing. Regular aerobic and strength activity can improve insulin response and cardiovascular health; the starting level should match ability, complications, and low-glucose risk. Sleep, dental care, vaccinations, stress support, and stopping tobacco are also part of diabetes care.

Supplements do not replace glucose-lowering treatment. Products promoted for “blood sugar support” may have uncertain benefit, variable ingredients, interactions, or liver and kidney risks. A registered dietitian or equivalent professional can help turn broad recommendations into meals that are realistic and nutritionally adequate.

Sources for this section: [1] [4] [6]

07

Monitoring and follow-up

Monitoring is broader than glucose and should be matched to treatment and complication risk.

Follow-up may include HbA1c or other glucose measures, blood pressure, cholesterol, kidney blood and urine tests, eye examinations, foot and nerve checks, dental care, vaccination review, and discussion of mood, sleep, sexual health, and treatment burden. Home glucose monitoring or continuous glucose monitoring is essential for some treatments and situations but not equally useful for everyone. The purpose and response to each measurement should be clear before collecting more data.

  • Bring a current medicine and supplement list, including products used only occasionally.
  • Ask how illness, fasting, travel, exercise, or missed meals should change the plan.
  • Discuss cost, supply, side effects, or complex routines early; these are treatment issues, not personal failures.

Sources for this section: [1] [5] [6]

08

Complications and long-term outlook

Over time, high glucose can injure large and small blood vessels and nerves, raising the risk of heart attack, stroke, kidney disease, vision loss, neuropathy, foot ulcers, infection, and sexual or bladder problems. These outcomes are not inevitable. Managing blood glucose together with blood pressure, cholesterol, tobacco exposure, kidney risk, and preventive care can substantially change risk. Treatment burden, depression, food insecurity, and access barriers also deserve direct attention because they can make an otherwise sound plan impossible to follow.

Sources for this section: [1] [6]

09

When to seek urgent help

An agreed sick-day plan should explain which medicines to continue or pause, when to check glucose or ketones, how to stay hydrated, and when to call for help. Severe low glucose can cause confusion, seizure, or unconsciousness. Very high glucose with dehydration or too little effective insulin can lead to dangerous hyperglycemic emergencies. Symptoms matter more than waiting for a particular number if a person is rapidly becoming unwell.

Sources for this section: [1] [6]

10

Questions and remaining uncertainty

Diabetes care changes as health, priorities, evidence, and access change. A guideline can describe average benefits and harms but cannot decide which burden or outcome matters most to one person. Ask for the reasoning behind targets and medicine choices, and revisit them after major illness, pregnancy planning, kidney changes, repeated low glucose, new complications, cost changes, or difficulty sustaining the routine.

  • What are my treatment goals, and which outcome is each part of the plan intended to improve?
  • Which side effects or readings should prompt a routine call, an urgent call, or emergency care?
  • What monitoring do I need for my medicines and complication risk—and what can be safely omitted?
  • How should the plan change during illness, fasting, travel, pregnancy, or a change in kidney function?

Sources for this section: [4] [5]

Sources

  1. Diabetes OverviewNational Institute of Diabetes and Digestive and Kidney Diseases · 2026
  2. Diabetes Tests & DiagnosisNational Institute of Diabetes and Digestive and Kidney Diseases · 2026
  3. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026Diabetes Care · 2026DOI 10.2337/dc26-S002
  4. Insulin, Medicines, & Other Diabetes TreatmentsNational Institute of Diabetes and Digestive and Kidney Diseases · 2026
  5. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026Diabetes Care · 2026DOI 10.2337/dc26-S009
  6. DiabetesWorld Health Organization · 2024